Is screening and treating asymptomatic chlamydia and gonorrhoea among pregnant women cost-effective to prevent preterm birth and low birth weight in Botswana?
Screening for <i>C. trachomatis</i> and <i>N. gonorrhoeae</i> infections has the potential to prevent serious adverse birth outcomes that contribute to childhood mortality, morbidity and high costs to the healthcare system. Additional research on the effectiveness of screening and treatment for these infections on preventing adverse birth outcomes is necessary to provide robust evidence that can inform cost-effectiveness analyses and decision-making.
Authors
- Neo Moshashane
- Kehumile Ramontshonyana
- Chibuzor M. Babalola (ORCID: https://orcid.org/0000-0003-3762-1620)
- Aamirah Mussa (ORCID: https://orcid.org/0000-0001-9152-5686)
- Adriane Wynn (ORCID: https://orcid.org/0000-0001-8067-3616)
- Caitlin M. Dugdale (ORCID: https://orcid.org/0000-0002-6604-6111)
- Merrian J. Brooks (ORCID: https://orcid.org/0000-0003-2607-6524)
- Chelsea Morroni (ORCID: https://orcid.org/0000-0002-2026-6039)
- Jeffrey David Klausner (ORCID: https://orcid.org/0000-0002-6922-7364)
- Rebecca Ryan
Institutions
- University of Southern California (US)
- Harvard University (US)
- University of California San Diego (US)
- Massachusetts General Hospital (US)
- Botswana Open University (BW)
- MRC Centre for Reproductive Health (GB)
- Botswana Harvard AIDS Institute Partnership (BW)
- University of Pennsylvania (US)
- University of Edinburgh (GB)
Publication Details
- Journal
- Sexually Transmitted Infections
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1136/sextrans-2025-056488
- Primary Topic
- Reproductive tract infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00